HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes

GLIA

Volumn 62, Issue 4, 2014, Pages 535-547

  Noack, Monika ^a   Leyk, Janina ^a   Richter Landsberg, Christiane ^a  

^a UNIVERSITY OF OLDENBURG   (Germany)

Author keywords

Glial cells; Microtubules; Tau isoform expression; Tauopathy; Tubastatin; Tubulin acetylation

Indexed keywords

GLIAL CELLS; MICROTUBULES; TAU ISOFORM EXPRESSION; TAUOPATHY; TUBASTATIN; TUBULIN ACETYLATION;

ACETYLATION; ANIMALS; ANIMALS, NEWBORN; BRAIN; CELLS, CULTURED; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; INDOLES; MICROTUBULES; OLIGODENDROGLIA; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, WISTAR; RNA, SMALL INTERFERING; TAU PROTEINS; TUBULIN;

EID: 84893803744     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22624     Document Type: Article

References (62)

1. Ballatore C, Lee VM, Trojanowski JQ. 2007. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8:663-672.
2. Bauer NG, Richter-Landsberg C. 2006. The dynamic instability of microtubules is required for aggresome formation in oligodendroglial cells after proteolytic stress. J Mol Neurosci 29:153-168.
3. Biernat J, Gustke N, Drewes G, Mandelkow EM, Mandelkow E. 1993. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11:153-163.
4. Boyault C, Gilquin B, Zhang Y, Rybin V, Garman E, Meyer-Klaucke W, Matthias P, Muller CW, Khochbin S. 2006. HDAC6-p97/VCP controlled polyubiquitin chain turnover. EMBO J 25:3357-3366.
5. Butler KV, Kalin J, Brochier C, Vistoli G, Langley B, Kozikowski AP. 2010. Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J Am Chem Soc 132:10842-10846.
6. Chiba Y, Takei S, Kawamura N, Kawaguchi Y, Sasaki K, Hasegawa-Ishii S, Furukawa A, Hosokawa M, Shimada A. 2012. Immunohistochemical localization of aggresomal proteins in glial cytoplasmic inclusions in multiple system atrophy. Neuropathol Appl Neurobiol 38:559-571.
7. Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT. 2009. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci 32:591-601.
8. Cohen TJ, Guo JL, Hurtado DE, Kwong LK, Mills IP, Trojanowski JQ, Lee VM. 2011. The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat Commun 2:252.
9. d'Ydewalle C, Bogaert E, Van Den Bosch L. 2012. HDAC6 at the intersection of neuroprotection and neurodegeneration. Traffic 13:771-779.
10. Dickson DW, Rademakers R, Hutton ML. 2007. Progressive supranuclear palsy: Pathology and genetics. Brain Pathol 17:74-82.
11. Ding H, Dolan PJ, Johnson GV. 2008. Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem 106:2119-2130.
12. Drewes G, Trinczek B, Illenberger S, Biernat J, Schmitt-Ulms G, Meyer HE, Mandelkow EM, Mandelkow E. 1995. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262. J Biol Chem 270:7679-7688.
13. Gendron TF, Petrucelli L. 2009. The role of tau in neurodegeneration. Mol Neurodegener 4:13.
14. Goldbaum O, Jensen PH, Richter-Landsberg C. 2008. The expression of tubulin polymerization promoting protein TPPP/p25alpha is developmentally regulated in cultured rat brain oligodendrocytes and affected by proteolytic stress. Glia 56:1736-1746.
15. Goldbaum O, Oppermann M, Handschuh M, Dabir D, Zhang B, Forman MS, Trojanowski JQ, Lee VM, Richter-Landsberg C. 2003. Proteasome inhibition stabilizes tau inclusions in oligodendroglial cells that occur after treatment with okadaic acid. J Neurosci 23:8872-8880.
16. Goldbaum O, Richter-Landsberg C. 2004. Proteolytic stress causes heat shock protein induction, tau ubiquitination, and the recruitment of ubiquitin to tau-positive aggregates in oligodendrocytes in culture. J Neurosci 24:5748-5757.
17. Goode BL, Chau M, Denis PE, Feinstein SC. 2000. Structural and functional differences between 3-repeat and 4-repeat tau isoforms. Implications for normal tau function and the onset of neurodegenetative disease. J Biol Chem 275:38182-38189.
18. Gorath M, Stahnke T, Mronga T, Goldbaum O, Richter-Landsberg C. 2001. Developmental changes of tau protein and mRNA in cultured rat brain oligodendrocytes. Glia 36:89-101.
19. Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL. 2003. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci USA 100:4389-4394.
20. Hideshima T, Bradner JE, Wong J, Chauhan D, Richardson P, Schreiber SL, Anderson KC. 2005. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. Proc Natl Acad Sci USA 102:8567-8572.
21. Himmelstein DS, Ward SM, Lancia JK, Patterson KR, Binder LI. 2012. Tau as a therapeutic target in neurodegenerative disease. Pharmacol Ther 136:8-22.
22. Hlavanda E, Kovacs J, Olah J, Orosz F, Medzihradszky KF, Ovadi J. 2002. Brain-specific p25 protein binds to tubulin and microtubules and induces aberrant microtubule assemblies at substoichiometric concentrations. Biochemistry 41:8657-8664.
23. Houtkooper RH, Pirinen E, Auwerx J. 2012. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13:225-238.
24. Irwin DJ, Cohen TJ, Grossman M, Arnold SE, Xie SX, Lee VM, Trojanowski JQ. 2012. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain 135:807-818.
25. Jellinger KA, Lantos PL. 2010. Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: An update. Acta Neuropathol 119:657-667.
26. Ji S, Doucette JR, Nazarali AJ. 2011. Sirt2 is a novel in vivo downstream target of Nkx2.2 and enhances oligodendroglial cell differentiation. J Mol Cell Biol 3:351-359.
27. Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, Yao TP. 2003. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115:727-738.
28. Komori T. 1999. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. Brain Pathol 9:663-679.
29. Lamark T, Johansen T. 2012. Aggrephagy: Selective disposal of protein aggregates by macroautophagy. Int J Cell Biol 2012:736905.
30. Lee G, Leugers CJ. 2012. Tau and tauopathies. Prog Mol Biol Transl Sci 107:263-293.
31. Lee MJ, Lee JH, Rubinsztein DC. 2013. Tau degradation: The ubiquitin-proteasome system versus the autophagy-lysosome system. Prog Neurobiol 105:49-59.
32. Li W, Zhang B, Tang J, Cao Q, Wu Y, Wu C, Guo J, Ling EA, Liang F. 2007. Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating alpha-tubulin. J Neurosci 27:2606-2616.
33. Li Y, Shin D, Kwon SH. 2013. Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes. FEBS J 280:775-793.
34. Liu J, Casaccia P. 2010. Epigenetic regulation of oligodendrocyte identity. Trends Neurosci 33:193-201.
35. Matsuyama A, Shimazu T, Sumida Y, Saito A, Yoshimatsu Y, Seigneurin-Berny D, Osada H, Komatsu Y, Nishino N, Khochbin S, et al. 2002. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J 21:6820-6831.
36. McMorris FA, Miller SL, Pleasure D, Abramsky O. 1981. Expression of biochemical properties of oligodendrocytes in oligodendrocyte x glioma cell hybrids proliferating in vitro. Exp Cell Res 133:395-404.
37. Miki Y, Mori F, Tanji K, Kakita A, Takahashi H, Wakabayashi K. 2011. Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions. Neuropathology 31:561-568.
38. Miller DW, Cookson MR, Dickson DW. 2004. Glial cell inclusions and the pathogenesis of neurodegenerative diseases. Neuron Glia Biol 1:13-21.
39. Min SW, Cho SH, Zhou Y, Schroeder S, Haroutunian V, Seeley WW, Huang EJ, Shen Y, Masliah E, Mukherjee C, et al. 2010. Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 67:953-966.
40. Muller R, Heinrich M, Heck S, Blohm D, Richter-Landsberg C. 1997. Expression of microtubule-associated proteins MAP2 and tau in cultured rat brain oligodendrocytes. Cell Tissue Res 288:239-249.
41. Nahhas F, Dryden SC, Abrams J, Tainsky MA. 2007. Mutations in SIRT2 deacetylase which regulate enzymatic activity but not its interaction with HDAC6 and tubulin. Mol Cell Biochem 303:221-230.
42. Neuhoff V, Philipp K, Zimmer HG, Mesecke S. 1979. A simple, versatile, sensitive and volume-independent method for quantitative protein determination which is independent of other external influences. Hoppe Seylers Z Physiol Chem 360:1657-1670.
43. North BJ, Marshall BL, Borra MT, Denu JM, Verdin E. 2003. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11:437-444.
44. Odagiri S, Tanji K, Mori F, Miki Y, Kakita A, Takahashi H, Wakabayashi K. 2013. Brain expression level and activity of HDAC6 protein in neurodegenerative dementia. Biochem Biophys Res Commun 430:394-399.
45. Olzmann JA, Li L, Chin LS. 2008. Aggresome formation and neurodegenerative diseases: Therapeutic implications. Curr Med Chem 15:47-60.
46. Pandey UB, Nie Z, Batlevi Y, McCray BA, Ritson GP, Nedelsky NB, Schwartz SL, DiProspero NA, Knight MA, Schuldiner O, Padmanabhan R, Hild M, Berry DL, Garza D, Hubbert CC, Yao TP, Baehrecke EH, Taylor JP. 2007. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447:859-863.
47. Perez M, Santa-Maria I, Gomez de Barreda E, Zhu X, Cuadros R, Cabrero JR, Sanchez-Madrid F, Dawson HN, Vitek MP, Perry G, Smith MA, Avila J. 2009. Tau-an inhibitor of deacetylase HDAC6 function. J Neurochem 109:1756-1766.
48. Richter-Landsberg C. 2008. The cytoskeleton in oligodendrocytes. Microtubule dynamics in health and disease. J Mol Neurosci 35:55-63.
49. Richter-Landsberg C, Gorath M. 1999. Developmental regulation of alternatively spliced isoforms of mRNA encoding MAP2 and tau in rat brain oligodendrocytes during culture maturation. J Neurosci Res 56:259-270.
50. Richter-Landsberg C, Heinrich M. 1996. OLN-93: A new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J Neurosci Res 45:161-173.
51. Richter-Landsberg C, Leyk J. 2013. Inclusion body formation, macroautophagy, and the role of HDAC6 in neurodegeneration. Acta Neuropathol 126:793-807.
52. Sergeant N, Delacourte A, Buee L. 2005. Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 1739:179-197.
53. Simoes-Pires C, Zwick V, Nurisso A, Schenker E, Carrupt PA, Cuendet M. 2013. HDAC6 as a target for neurodegenerative diseases: What makes it different from the other HDACs? Mol Neurodegener 8:7.
54. Song J, Goetz BD, Baas PW, Duncan ID. 2001. Cytoskeletal reorganization during the formation of oligodendrocyte processes and branches. Mol Cell Neurosci 17:624-636.
55. Southwood CM, Peppi M, Dryden S, Tainsky MA, Gow A. 2007. Microtubule deacetylases, SirT2 and HDAC6, in the nervous system. Neurochem Res 32:187-195.
56. Tang BL, Chua CE. 2008. SIRT2, tubulin deacetylation, and oligodendroglia differentiation. Cell Motil Cytoskeleton 65:179-182.
57. Tokesi N, Lehotzky A, Horvath I, Szabo B, Olah J, Lau P, Ovadi J. 2010. TPPP/p25 promotes tubulin acetylation by inhibiting histone deacetylase 6. J Biol Chem 285:17896-17906.
58. True O, Matthias P. 2012. Interplay between histone deacetylases and autophagy-From cancer therapy to neurodegeneration. Immunol Cell Biol 90:78-84.
59. Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG. 2008. Multiple system atrophy: A primary oligodendrogliopathy. Ann Neurol 64:239-246.
60. Zhang Y, Gilquin B, Khochbin S, Matthias P. 2006. Two catalytic domains are required for protein deacetylation. J Biol Chem 281:2401-2404.
61. Zhang Y, Li N, Caron C, Matthias G, Hess D, Khochbin S, Matthias P. 2003. HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J 22:1168-1179.
62. Zilberman Y, Ballestrem C, Carramusa L, Mazitschek R, Khochbin S, Bershadsky A. 2009. Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6. J Cell Sci 122:3531-3541.